We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current ACET market cap is 101.44M. The company's latest EPS is USD -1.6168 and P/E is -1.41.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -22.99M | -31.57M | -33.32M | -34.89M | -52.26M |
Net Income | -22M | -29.88M | -30.88M | -32.4M | -49.89M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 17.9M | 9.73M | 24.99M |
Operating Income | -39.71M | -85.46M | -39.19M | -62.04M | -72.55M |
Net Income | -37.61M | -82.74M | -36.68M | -62M | -69.79M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 354.3M | 330.69M | 304.97M | 277.63M | 233.26M |
Total Liabilities | 36.65M | 38.35M | 38.76M | 38.57M | 38.58M |
Total Equity | 317.66M | 292.34M | 266.22M | 239.06M | 194.68M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 109.94M | 93.91M | 153.84M | 338.94M | 330.69M |
Total Liabilities | 5.74M | 12.21M | 44.01M | 35.81M | 38.35M |
Total Equity | 104.2M | 81.7M | 109.83M | 303.13M | 292.34M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -25.93M | -44.77M | -24.09M | -48.99M | -70.23M |
Investing | -10.29M | -16.78M | -1.92M | -3.42M | -4.33M |
Financing | 41.21M | 41.51M | -7k | 219k | 160k |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -35.45M | -73.68M | -43.85M | -51.05M | -44.77M |
Investing | -100.8M | 44.13M | 115.22M | -2.8M | -16.78M |
Financing | 89.94M | 56.45M | 303k | 242.69M | 41.51M |
Market Cap | 101.44M |
Price to Earnings Ratio | -1.41 |
Price to Sales Ratio | 3.94 |
Price to Cash Ratio | 0.38 |
Price to Book Ratio | 0.34 |
Dividend Yield | - |
Shares Outstanding | 43.16M |
Average Volume (1 week) | 950.21k |
Average Volume (1 Month) | 1.54M |
52 Week Change | -60.10% |
52 Week High | 7.50 |
52 Week Low | 1.10 |
Spread (Intraday) | 0.01 (0.43%) |
Company Name | Adicet Bio Inc |
Address |
corporation trust center 1209 orange st wilmington, delaware 19801 |
Website | https://www.adicetbio.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions